ストックスクリーナーアプリを入手
17.63
3.66%
-0.67
プレマーケット:
17.63
前日終値:
$18.30
開ける：
$18.4
24時間の取引高:
578.15K
Relative Volume:
1.11
時価総額：
$1.04B
収益：
-
当期純損益:
$-85.21M
株価収益率:
-9.328
EPS:
-1.89
ネットキャッシュフロー:
$-68.53M
1週間 パフォーマンス:
-24.72%
1か月 パフォーマンス:
-12.33%
6か月 パフォーマンス:
-3.50%
1年 パフォーマンス:
-39.21%
1日の値動き範囲:
$16.80
$18.40
1週間の範囲:
$16.80
$23.31
52週間の値動き範囲:
$13.30
$29.40
Enliven Therapeutics Inc Stock (ELVN) Company Profile
ELVN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ELVN
Enliven Therapeutics Inc
|
17.63 | 1.08B | 0 | -85.21M | -68.53M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-16 | 開始されました | Goldman | Buy |
| 2024-12-13 | 開始されました | BTIG Research | Buy |
| 2024-09-09 | 開始されました | H.C. Wainwright | Buy |
| 2024-06-11 | 開始されました | Robert W. Baird | Outperform |
| 2024-04-09 | 開始されました | Mizuho | Buy |
| 2023-03-29 | 開始されました | Jefferies | Buy |
すべてを表示
Enliven Therapeutics Inc (ELVN) 最新ニュース
What analyst consensus says on Enliven Therapeutics Inc. stockTrade Analysis Summary & Weekly High Return Stock Opportunities - newser.com
Published on: 2025-11-09 23:45:00 - newser.com
Is Enliven Therapeutics Inc. stock a contrarian buy2025 Market Overview & Smart Allocation Stock Reports - newser.com
Enliven Therapeutics Inc. stock daily chart insightsStop Loss & High Conviction Investment Ideas - newser.com
Real time breakdown of Enliven Therapeutics Inc. stock performanceJuly 2025 Selloffs & Smart Investment Allocation Insights - newser.com
Using data filters to optimize entry into Enliven Therapeutics Inc.Breakout Watch & Daily Stock Trend Watchlist - newser.com
Will Enliven Therapeutics Inc. stock continue dividend increasesJuly 2025 Drop Watch & Weekly Momentum Picks - fcp.pa.gov.br
Can Enliven Therapeutics Inc. stock deliver strong Q4 earningsJobs Report & Free AI Powered Buy and Sell Recommendations - newser.com
Is Enliven Therapeutics Inc. stock attractive for retirement portfoliosMarket Performance Summary & Real-Time Chart Pattern Alerts - fcp.pa.gov.br
Head-To-Head Comparison: Enliven Therapeutics (NASDAQ:ELVN) vs. NLS Pharmaceutics (NASDAQ:NCEL) - Defense World
Is Enliven Therapeutics Inc. stock positioned well for digital economyQuarterly Profit Review & Technical Pattern Recognition Alerts - newser.com
Enliven Therapeutics, Inc. (ELVN) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Published on: 2025-11-05 22:17:31 - newser.com
Is Enliven Therapeutics Inc. stock cheap compared to fundamentalsDollar Strength & Consistent Growth Equity Picks - newser.com
Published on: 2025-11-05 21:38:45 - newser.com
Enliven Therapeutics Inc. recovery potential after sell offJuly 2025 Big Picture & AI Optimized Trade Strategies - newser.com
(ELVN) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Stocks of Enliven Therapeutics Inc (ELVN) are poised to climb above their peers - setenews.com
Enliven Therapeutics Inc Stock Analysis and ForecastInstitutional Holding Changes & Low Risk Trading Alerts - earlytimes.in
Enliven Therapeutics (NASDAQ:ELVN) Stock Price Down 12.3%Here's What Happened - MarketBeat
Is Enliven Therapeutics Inc. stock a buy for dividend growthQuarterly Portfolio Summary & Long-Term Growth Plans - fcp.pa.gov.br
Fed Watch: Is Enliven Therapeutics Inc. stock positioned well for digital economyQuarterly Portfolio Review & Risk Managed Investment Entry Signals - fcp.pa.gov.br
Enliven Therapeutics showcases promising results for ELVN-001 in CML trial - Traders Union
Enliven (NASDAQ: ELVN) presents ELVN-001 CML data at ASH 2025 with >1 log transcript declines - Stock Titan
Applying sector rotation models to Enliven Therapeutics Inc.Weekly Profit Summary & Daily Risk Controlled Trade Plans - newser.com
Why Enliven Therapeutics Inc. stock appeals to dividend seekers2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Is Enliven Therapeutics Inc. stock a safe haven assetWeekly Earnings Recap & Fast Entry Momentum Alerts - newser.com
Enliven Therapeutics Inc (ELVN) 財務データ
収益
当期純利益
現金流量
EPS
Enliven Therapeutics Inc (ELVN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Kintz Samuel | PRESIDENT AND CEO |
Oct 17 '25 |
Sale |
21.33 |
12,500 |
266,654 |
902,892 |
5.44%
0.70%
大文字化:
|
ボリューム (24 時間):